Call Now Open
Oxford-Harrington Rare Disease Scholar Award
February 06, 2024
The Oxford-Harrington Rare Disease Centre (OHC), a partnership between the University of Oxford, U.K. and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio, is seeking innovative projects for its 2024 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice. In addition to grant funding, the award includes drug and business development support from pharma-experienced industry leaders with a track record of bringing therapeutics to market. Awardees have access to the Oxford-Harrington Rare Disease Centre Therapeutics Accelerator, which receives support from a partnership between University of Oxford, Oxford Science Enterprises, and University Hospitals in Cleveland, Ohio.
The OHC’s 2024 Rare Disease Scholar Award seeks novel approaches to treat rare diseases, with a focus on neurological disorders, developmental and metabolic disorders, and rare cancers. Applications directed to other rare, genetic indications with a high unmet need are also of interest. Any therapeutic modality will be considered. Intellectual property rights are retained by the award recipient or their institution.
Researchers in the U.S., U.K., and Canada are eligible to apply for this award. Successful applicants will receive:
Award recipients will be selected by the OHC Scientific Advisory Board and announced in October 2024. Up to 10 OHC Scholars will be selected.
The deadline to submit a full application is March 26, 2024 at 11:59p.m. ET.
Learn more and apply: OxfordHarrington.org/Award